Dr. Shang-Chin Huang is a hepatologist and a clinical assistant professor at National Taiwan University in Taipei, Taiwan. His research focuses on the interplay between chronic hepatitis B (CHB) and metabolic dysfunction–associated steatotic liver disease (MASLD), with an emphasis on viral replication, disease progression, and long-term clinical outcomes. His work has been widely published in leading journals, including the Journal of Hepatology, Clinical Gastroenterology and Hepatology, and American Journal of Gastroenterology. Highly active in the international hepatology community, he serves on the Emerging Leaders Committee of the Asian Pacific Association of Gastroenterology (APAGE) and contributed as a panel member to the clinical practice guidelines on CHB issued by the Asian Pacific Association for the Study of the Liver (APASL). His academic contributions have been recognized with multiple honors, including the 2025 APASL Rising Star Award. He is dedicated to bridging frontline translational insights with real-world clinical care.